PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Clinical Pharmacology, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • e2020134210.1084/jem.20201342
?:hasPublicationType
?:journal
  • The Journal of experimental medicine
is ?:pmid of
?:pmid
?:pmid
  • 32678432
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Blocking inflammation on the way: Rationale for CXCR2 antagonists for the treatment of COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all